Want to join the conversation?
$VRTX has begun marketing cystic fibrosis drug Orkambi in the U.S. and will recognize its first net product revenue from Orkambi in 3Q15. $VRTX believes that there currently are about 8,500 patients in the U.S. who are eligible for treatment with Orkambi.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!